Tempest Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Tempest Therapeutics, Inc. (TPST) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 147.74 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-13
- Tempest Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 147.74K shares.
- Tempest Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 0.00 shares.
- Tempest Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 0.00 shares.
- Tempest Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 0.00 shares.
- Tempest Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 0.00 shares, a 100.00% decline from fiscal 2024.
- Tempest Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 16.03K shares, a 94.78% decline from fiscal 2023.
- Tempest Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 307.02K shares, a 108.68% increase from fiscal 2022.
- Tempest Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 147.12K shares, a 29.60% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 147.74K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 147.74K shares 10-Q · filed 2026-08-13 | 147.74K shares derived: sum of 3 quarters · filed 2026-08-13 | 147.74K shares derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-14 | 0.00 shares derived: sum of 2 quarters · filed 2026-05-14 | 0.00 shares derived: sum of 3 quarters · filed 2026-05-14 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-30 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-13 | 0.00 shares 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 0.00 shares derived: sum of 2 quarters · filed 2026-08-13 | 0.00 shares 10-Q · filed 2025-11-05 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 0.00 shares 10-Q · filed 2026-08-13 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-13 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-14 | 0.00 shares derived: sum of 2 quarters · filed 2026-05-14 | 0.00 shares derived: sum of 3 quarters · filed 2026-05-14 | 741.00 shares derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-30 | 741.00 shares derived: sum of 3 quarters · filed 2026-03-30 | 16.03K shares 10-K · filed 2026-03-30 | 208.38K shares 10-K · filed 2025-03-27 | |||
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 741.00 shares derived: sum of 2 quarters · filed 2025-11-05 | 16.03K shares 10-Q · filed 2025-11-05 | 208.38K shares 10-Q · filed 2024-11-12 | 272.85K shares derived: sum of 4 quarters · filed 2025-11-05 | |||
| 2024-06-30 | 741.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | 16.03K shares 10-Q · filed 2025-08-11 | 208.38K shares 10-Q · filed 2024-08-08 | 272.85K shares derived: sum of 3 quarters · filed 2025-08-11 | 278.97K shares derived: sum of 4 quarters · filed 2025-08-11 | |||
| 2024-03-31 | 15.29K shares 10-Q · filed 2025-05-13 | 198.74K shares 10-Q · filed 2024-05-09 | 272.11K shares derived: sum of 2 quarters · filed 2025-05-13 | 278.23K shares derived: sum of 3 quarters · filed 2025-05-13 | 293.12K shares derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | 256.82K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 262.94K shares derived: sum of 2 quarters · filed 2025-03-27 | 277.84K shares derived: sum of 3 quarters · filed 2025-03-27 | 307.02K shares 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | 6.12K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 21.01K shares derived: sum of 2 quarters · filed 2024-11-12 | 50.19K shares 10-Q · filed 2024-11-12 | 141.08K shares derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | 14.89K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 44.08K shares 10-Q · filed 2024-08-08 | 134.96K shares derived: sum of 3 quarters · filed 2024-08-08 | 156.50K shares derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | 29.18K shares 10-Q · filed 2024-05-09 | 120.07K shares derived: sum of 2 quarters · filed 2024-05-09 | 141.60K shares derived: sum of 3 quarters · filed 2024-05-09 | 159.10K shares derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | 90.89K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | 112.42K shares derived: sum of 2 quarters · filed 2024-03-19 | 129.92K shares derived: sum of 3 quarters · filed 2024-03-19 | 147.12K shares 10-K · filed 2024-03-19 | ||||
| 2022-09-30 | 21.53K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | 39.03K shares derived: sum of 2 quarters · filed 2023-11-08 | 56.23K shares 10-Q · filed 2023-11-08 | 69.30K shares derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | 17.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 34.70K shares 10-Q · filed 2023-08-10 | 47.77K shares derived: sum of 3 quarters · filed 2023-08-10 | 141.91K shares derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | 17.20K shares 10-Q · filed 2023-05-10 | 30.26K shares derived: sum of 2 quarters · filed 2023-05-10 | 124.41K shares derived: sum of 3 quarters · filed 2023-05-10 | 125.06K shares derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | 13.06K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | 107.20K shares derived: sum of 2 quarters · filed 2023-03-22 | 107.85K shares derived: sum of 3 quarters · filed 2023-03-22 | 113.52K shares 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | 94.14K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 94.79K shares derived: sum of 2 quarters · filed 2022-11-08 | 100.46K shares 10-Q · filed 2022-11-08 | -444.05K shares derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | 649.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 6.32K shares 10-Q · filed 2022-08-15 | -538.20K shares derived: sum of 3 quarters · filed 2022-08-15 | -374.37K shares derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | 5.67K shares 10-Q · filed 2022-05-13 | 719.41K shares 10-Q · filed 2021-05-13 | -538.85K shares derived: sum of 2 quarters · filed 2022-05-13 | -375.02K shares derived: sum of 3 quarters · filed 2022-05-13 | 12.76K shares derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-12-31 | -544.51K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -380.68K shares derived: sum of 2 quarters · filed 2022-03-29 | 7.09K shares derived: sum of 3 quarters · filed 2022-03-29 | 22.84K shares 10-K · filed 2022-03-29 | 612.43K shares 10-K · filed 2021-03-29 | |||
| 2020-09-30 | 163.83K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 551.61K shares derived: sum of 2 quarters · filed 2020-11-09 | 567.36K shares 10-Q · filed 2020-11-09 | 692.38K shares derived: sum of 4 quarters · filed 2021-03-29 | ||||
| 2020-06-30 | 387.78K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 403.53K shares 10-Q · filed 2020-08-10 | 528.55K shares derived: sum of 3 quarters · filed 2021-03-29 | 690.92K shares derived: sum of 4 quarters · filed 2021-03-29 | ||||
| 2020-03-31 | 15.75K shares 10-Q · filed 2020-05-08 | 140.78K shares derived: sum of 2 quarters · filed 2021-03-29 | 303.14K shares derived: sum of 3 quarters · filed 2021-03-29 | 321.97K shares derived: sum of 4 quarters · filed 2021-03-29 | ||||
| 2019-12-31 | 125.03K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | 287.39K shares derived: sum of 2 quarters · filed 2021-03-29 | 306.23K shares derived: sum of 3 quarters · filed 2021-03-29 | 394.36K shares 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | 162.36K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | 181.20K shares derived: sum of 2 quarters · filed 2019-11-13 | 269.33K shares 10-Q · filed 2019-11-13 | |||||
| 2019-06-30 | 18.83K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | 106.96K shares 10-Q · filed 2019-08-12 | ||||||
| 2019-03-31 | 88.13K shares 10-Q · filed 2019-05-15 | |||||||
| 2018-12-31 | 66.60K shares 10-K · filed 2020-03-11 | |||||||
| 2017-12-31 | 16.32K shares 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |